Sustained-release tablets (SR-tablet), prepared with hydrogenated soya phospholipids, gave slow release of theophylline and sodium diclofenac into a solvent at pH 6.8, in an in vitro study. The release profile of theophylline from the SR-tablet remained unchanged at pH values between 2.0 and 6.8. However, the release of diclofenac from the SR-tablet into a solvent at pH 2.0 was very slight, due to the low solubility at pH 2.0. The release of both drugs seems to occur predominantly by a leaching mechanism, as proposed by Higuchi. The oral administration of SRtablets to dogs avoided a transient peak of drug concentration in the plasma and maintained plasma drug concentrations at higher levels for a longer period, in comparison with the oral administration of theophylline in suspension form or a commercial tablet of sodium diclofenac. (
When a linear relationship is observed between F and the square root of time (as shown in Figs. 1 and 2 ), the release of drugs from SR-tablet seems to occur by the leaching mechanism proposed by Higuchi,8) according to Eq. 2.
Where Q = the amount of drug released after time t per unit exposed area; D = the diffusivity of the drug in the permeating fluid; t = the tortuosity factor of the capillary system; A= the total amount of drug present in the matrix per unit volume; Cs the solubility of drug in the permeating fluid; and e= the porosity of the matrix. Thus, the amount of drug released from an SR-tablet after time t can be represented by Eq. 3.
Where Sq= the total exposed area of an SR-tablet. When the total volume of an SR-tablet is presented by V0, F in Eq. 1 is given by Eq. 4.
Thus, Eq. 5 is obtained from Eqs. 2 and 4.
In Eq. 5, k represents the slope of the straight line obtained when the F values are plotted against the square root of time, and it may represent an apparent overall control factor for the release of drug from an SR-tablet; i.e., a small value of k implies slow release of drug from the tablet. Table II) was observed between the fraction of diclofenac released (F in Eqs. 1 and 5) and the square root of immersion time up to 24 h, when the tablet was shaken at 40 cycle/min (Fig.  2B) . It is considered that the release of diclofenac from an SR-tablet may also occur by the leaching mechanism. The release of diclofenac under the above conditions was about 60% at 24 h, though complete release of theophylline was observed (Fig. 2) . This slow release of diclofenac is due to the low solubility of diclofenac, since the release of the drug from the formulation in the leaching system according the Eq.5 is dependent on the drug solubility. When the tablet was shaken at pH 6.8 and at 100 cycle/min, a linear relationship was obtained between the fraction of diclofenac released and the square root of time up to 8 h. However, after 8 h, the release of diclofenac from the tablet under these conditions was greater than that expected from a leaching system, as observed with theophylline. This unexpectedly large release of diclofenac also seemed to be due to the disintegration of SR-tablets by vigorous shaking.
When an SR-tablet was immersed in the solvent at pH 6.8 after incubation for 1 h in the solvent at pH 2.0, the release profile of diclofenac similar to that in the solvent of pH 6.8 alone after a lag time (Fig. 2C) . The observation of a lag time on changing the solvent from pH 2.0 to 6.8 may be due to a period of displacement of the initial solvent of pH 2.0 by the solvent of pH 6.8
An in Vivo Absorption Study in Dogs
After an oral administration of theophylline in suspension form at a dose of 25 mg to a dog, a transient high theophylline concentration in the plasma was observed with a maximum level of more than 30 pg/ml at 4 h (Fig. 3) . However, administration of theophylline in an SRtablet avoided the transient high theophylline concentration, and a maximum plasma theophylline concentration of about 10 pg/ml was observed at about 6 h. Further, the concentration of theophylline at 30 h was about 3 pg/ml in the case of the SR-tablet but less 
